Boyu Hu
( out of 335 reviews )

Boyu Hu, MD

Languages spoken: English

  • Dr. Boyu Hu joined the Division of Hematology/Hematologic Malignancies in 2018. He specializes in treating patients with chronic lymphocytic leukemia and lymphoma. He completed his internal medicine residency at The Hospital of the University of Pennsylvania and then his fellowship training in Hematology/Oncology at the University of Texas MD Anderson Cancer Center. His research focuses on characterizing the genomic landscape within lymphoid malignancies to use not only as prognostic markers within the diseases but also as biomarkers to develop novel targeted therapies and therapy combinations to treat each condition. He is an active member within the Southwest Oncology Group and is the principle investigator on multiple phase I, II and III clinical trials.

    Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    4.9 /5
    ( out of 335 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 20, 2023

    Dr. Hu is always courteous and helpful. He listens to me and takes my questions seriously. He includes me in care taking decisions. I have always felt fortunate that he was my providing physician.

    August 19, 2023

    Knowledgeable, personal and very efficient

    August 17, 2023

    Dr Hu is a great professional caregiver. Very pleasant and thorough in explaining the situation and results. He respects my decision if I decline some of the recommended vaccines or immunizations. Never pushes himself on the patient but allows them to decide after giving them a comprehensive understanding of procedures that are best for them.

    See More Patient Comments

  • Dr. Boyu Hu joined the Division of Hematology/Hematologic Malignancies in 2018. He specializes in treating patients with chronic lymphocytic leukemia and lymphoma. He completed his internal medicine residency at The Hospital of the University of Pennsylvania and then his fellowship training in Hematology/Oncology at the University of Texas MD Anderson Cancer Center. His research focuses on characterizing the genomic landscape within lymphoid malignancies to use not only as prognostic markers within the diseases but also as biomarkers to develop novel targeted therapies and therapy combinations to treat each condition. He is an active member within the Southwest Oncology Group and is the principle investigator on multiple phase I, II and III clinical trials.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Hematology/Oncology - University of Texas MD Anderson Cancer Center Fellow
    Internal Medicine - Hospital of the University of Pennsylvania Resident
    Internship Internal Medicine - Hospital of the University of Pennsylvania Intern
    Medicine - Case Western Reserve University School of Medicine M.D.
    Undergraduate Duke University B.S.